Lipocine (LPCN) Director John W. Higuchi Buys 12,561 Shares

What Happened John W. Higuchi, a director of Lipocine Inc. (LPCN), reported an open-market purchase of 12,561 shares on 2026-09-28 at $2.16 per share, a total transaction value of approximately $27,132. The Form 4 classifies the transaction as a purchase (code P), indicating Higuchi acquired the shares rather than selling or receiving them as an award.

Key Details

• Transaction date: 2026-09-28; filing date: 2026-09-30 (appears timely — within the standard 2 business days for Form 4).
• Price per share: $2.16; shares acquired: 12,561; total ≈ $27,131.76 (reported ≈ $27,132).
• Transaction type: Open-market purchase (code P).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other special footnotes were indicated in the provided details.

Context This was a straightforward cash purchase reported by a company director. Purchases by insiders can be interpreted by investors as a positive signal of confidence, but they do not guarantee future performance. No option exercises, gifts, or complex derivatives were involved in this reported transaction.